Modern Diagnostic & Research Centre IPO
- Issue price
- ₹90
- Listing price
- ₹90
- 0.00%
- Current price
- ₹71.9
- -20.11%
- Subscribed
- 350.49x
- Issue size
- —
- Listed on
- 7 Jan 2026
IPO timeline
- Opens31 DecWed
- Closes2 JanFri
- Allotment5 JanMon
- Refunds6 JanTue
- Demat credit6 JanTue
- Listing7 JanWed
Issue details
- Price band
- ₹85 – ₹90 per share
- Issue size
- —
- Fresh issue
- Not available
- Offer for sale
- Not available
- Issue type
- Fresh capital only
- Face value
- — per share
- Lot size
- 1,600 shares
- Minimum investment
- ₹1,44,000
- Listing on
- BSE SME
- Exchange code
- MDRC.BO · 7526
Lot size and investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | ₹1,44,000 |
| Retail (Max) | 1 | 1,600 | ₹1,44,000 |
| HNI (Min) | 2 | 3,200 | ₹2,88,000 |
Reservation
- QIB
- 19,44,000 shares (49.94% of the Offer)
- NII
- 5,85,600 shares (15.04% of the Offer)
- Retail
- 13,63,200 shares (35.02% of the Offer)
Allotment status
The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).
Check allotment on MUFG Intime India- 1Open the registrar's allotment page and select this IPO from the list.
- 2Enter your PAN, application number or DP / Client ID.
- 3Submit to see the number of shares allotted, if any.
- Basis of allotment
- 5 Jan 2026
- Refunds initiated
- 6 Jan 2026
- Shares credited to demat
- 6 Jan 2026
- Listing
- 7 Jan 2026
Grey market premium (GMP)
- Current GMP
- ₹14
- +16.00%
- Estimated listing price
- ₹104
- Issue price ₹90
- Highest
- ₹14
- 6 Jan
- Lowest
- ₹14
- 6 Jan
GMP by day (₹ per share)
Day-wise GMP table
| Date | GMP | Premium | Est. listing |
|---|---|---|---|
| 10 Jan 2026 | ₹14 | +16.00% | ₹104 |
| 9 Jan 2026 | ₹14 | +16.00% | ₹104 |
| 6 Jan 2026 | ₹14 | +16.00% | ₹104 |
- Kostak rate
- ₹0
- Subject to sauda
- ₹18,000
GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.
Subscription status
- QIB193.51x
- NII (HNI)519.38x
- Retail342.46x
| Category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| Qualified Institutional Buyers (QIB) | 7,82,400 | 15,14,00,000 | 193.51x |
| Non-Institutional Investors (NII) | 7,92,000 | 41,13,45,600 | 519.38x |
| Retail Individual Investors (RII) | 13,63,200 | 46,68,44,800 | 342.46x |
| Total | 29,37,600 | 1,02,95,90,400 | 350.49x |
Financials
- P/E Ratio
- 11.33
- EPS (₹)
- 7.94
- RoCE
- 36.18%
- RoNW
- 43.27%
- PAT Margin
- 11.51%
Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.
| Period ended | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 77.86 | 64.57 | 49.49 | 36.54 |
| Total Income | 22.67 | 78.80 | 68.67 | 56.61 |
| Profit After Tax | 3.00 | 8.97 | 5.79 | -5.73 |
| EBITDA | 5.86 | 17.96 | 11.05 | -0.99 |
| NET Worth | 23.72 | 20.73 | 11.76 | 5.96 |
| Reserves and Surplus | 12.72 | 9.73 | 10.76 | 4.96 |
| Total Borrowing | 30.38 | 22.09 | 20.46 | 15.31 |
Peer comparison
| Company | Issue size | P/E | RoNW | PAT margin | Subscribed | Listing gain |
|---|---|---|---|---|---|---|
| Modern Diagnostic & Research Centre This IPO | — | 11.33 | 43.27% | 11.51% | 350.49x | 0.00% |
| Accretion Nutraveda SME · listed 4 Feb 2026 | — | 20.02 | 48.85% | 16.33% | 1.77x | +48.06% |
| Hannah Joseph Hospital SME · listed 1 Feb 2026 | — | 15.52 | 14.74% | 9.30% | 1.51x | -7.14% |
| KRM Ayurveda SME · listed 27 Jan 2026 | — | 23.73 | 67.86% | 15.80% | 74.43x | +27.48% |
| Goldline Pharmaceutical SME · listed 19 May 2026 | ₹12 Cr | 13.93 | 27.37% | 10.09% | 781.85x | +38.95% |
| Himalaya Nutravedics India SME · listed 29 Sep 2026 | ₹26.5 Cr | 12.63 | 45.12% | 17.16% | 2.24x | +11.32% |
| Speciality Medicines SME · listed 30 Mar 2026 | ₹29 Cr | 10.49 | 28.30% | 14.77% | 2.19x | 0.00% |
Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.
About Modern Diagnostic & Research Centre
Modern Diagnostic & Research Centre was established with the aim of providing reliable and advanced diagnostic services to patients and healthcare providers. Over the years, the company has built a strong presence in the medical diagnostics space by adopting modern technology and maintaining quality standards. Promoted by experienced healthcare professionals, the centre focuses on delivering accurate and timely reports, helping doctors in effective diagnosis and treatment planning. The company offers a wide range of services including pathology testing, radiology services such as X-ray, ultrasound, and other specialised diagnostic solutions. Its business model is centred around operating diagnostic centres and laboratories, generating revenue through test-based services and partnerships with hospitals and clinics. With a focus on customer trust, affordability, and expansion into new locations, the company continues to strengthen its footprint in the healthcare diagnostics sector.
Objects of the issue
- Funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories ₹20.69 Cr
- Funding Working Capital Requirement₹8 Cr
- Repayment of certain outstanding borrowings availed by the Company₹1 Cr
- General Corporate Expenses₹3.33 Cr
Promoters and shareholding
Asha Yadav, Deepali Yadav, Devendra Singh Yadav and Jitendra Singh
- Promoter holding, pre-issue
- 99.99%
- Promoter holding, post-issue
- 72.85%
Registrar, lead managers and documents
Lead manager
Company contact
Plot No H-64, 1st Floor BLK-H, Bali Nagar City landmark near Khetar Pal Hospital, Ramesh Nagar, West, Delhi, New Delhi, 110015
9999474297
compliance@mdrcindia.comModern Diagnostic & Research Centre IPO: common questions
When does the Modern Diagnostic & Research Centre IPO open and close?
The Modern Diagnostic & Research Centre IPO opens on 31 Dec 2025 and closes on 2 Jan 2026.
What is the price band of the Modern Diagnostic & Research Centre IPO?
The price band is ₹85 – ₹90 per share, with a lot size of 1,600 shares and a minimum investment of ₹1,44,000.
What is the GMP of the Modern Diagnostic & Research Centre IPO?
The last reported grey market premium is ₹14 per share as of 10 Jan 2026, 02:42 PM IST. GMP is unofficial and changes frequently.
When is the Modern Diagnostic & Research Centre IPO allotment?
The basis of allotment is expected on 5 Jan 2026. Allotment status can be checked with the registrar, MUFG Intime India Private Limited.
When will the Modern Diagnostic & Research Centre IPO list?
The shares listed on 7 Jan 2026 on BSE SME.
For business owners
Your company could be the next listing
Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.
- Eligibility check against NSE Emerge, BSE SME and Main Board norms
- Indicative valuation and issue size for your business
- A clear timeline from readiness to listing day
Check if your business can list
Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.
Prefer to talk? Call +91 95377 67203